stockrowDare Bioscience, Inc. (DARE) vs TScan Therapeutics, Inc. (TCRX)
- Dare Bioscience, Inc. DARE 0.64 +3.23%
- TScan Therapeutics, Inc. TCRX 0.18 0.00%
Dare Bioscience, Inc. and TScan Therapeutics, Inc. are both Biotechnology companies. Dare Bioscience, Inc. and TScan Therapeutics, Inc. are of similar size ($12.3M and $12.3M). Dare Bioscience, Inc. grew revenue faster over the last twelve months: 7,817.5% against 2.15%. Dare Bioscience, Inc. has the higher net margin (−804.3% vs −1,655.4%) and the higher return on invested capital (0.00% vs −4,588.2%). Across the 17 metrics below, Dare Bioscience, Inc. leads on 10 and TScan Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | DARE | TCRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 58.84% | 100.00% | 68.51% |
| Operating margin | (813.35%) | (1,695.15%) | 0.00% |
| Net margin | (804.33%) | (1,655.35%) | 0.00% |
| Free cash flow margin | (849.36%) | (1,665.18%) | 0.00% |
| Return on equity | 165.29% | (95.80%) | (51.96%) |
| Return on assets | (62.16%) | (50.09%) | (46.06%) |
| Return on invested capital | 0.00% | (4,588.23%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack